The Professional’s Playbook

The first six lessons gave you the tools. This one shows a professional using all of them on a single stock — from first idea to a written trading plan you actually track. We’ll walk one company end to end: how a disciplined investor plans the work, runs the analysis, decides, sizes the position, writes entry and exit rules, and monitors the thesis over time. Every number here is illustrative and rounded for teaching — it is not current data and not a recommendation.

What you’ll learn

• The repeatable loop a professional runs on every idea
• How to turn “I like this company” into a written thesis and a research plan
• How the quality → statements → valuation → market lenses combine into one decision
• How to size a position and write an entry/exit trading plan
• How to track a thesis and know when it’s broken
• How the same process adapts to a very different kind of stock

The professional’s loop

Amateurs buy on a tip and then watch the price. Professionals run a process — the same loop every time — so the decision is repeatable, reviewable, and improvable.

Key idea: the goal isn’t to be right once — it’s to run a process you can repeat and audit. A written plan turns investing from a bet into a craft. Being wrong with a plan teaches you something; being right without one teaches you nothing.

Let’s run the loop on a real company.

Step 0 · Meet the example

Our example is Apple (AAPL) — a business almost everyone understands, which makes the method easy to see. To keep the focus on process, assume our data pull returns these rounded, illustrative figures (again: for teaching, not live data):

That’s the raw material. The job now is to turn it into a decision.

Step 1 · Write the thesis first

Before opening a spreadsheet, a professional writes the thesis in one sentence — it forces clarity and gives you something to disprove later.

Thesis: Apple is a wide-moat cash machine whose services growth and relentless buybacks compound per-share value — and I want to own it if I can buy at a price that leaves a margin of safety.

Then the two-sided version, because a thesis you can’t argue against is a hope, not a thesis:

In the plugin: stock-eval produces a fast quality/value/growth read to sanity-check a thesis before you invest hours; competitor-analysis pressure-tests the moat.

Step 2 · The research plan

The thesis implies a checklist of things that must be true. Write them as questions, then assign each to a lesson and a skill. This is your research plan — you’re done when every box is answered.

Step 3 · Is it a good business? (quality)

Run the quality lens. With our illustrative numbers:

• Returns on capital: ROIC comfortably above any reasonable WACC (~8–9%) — the hallmark of a value-creating business.
• Margins: ~46% gross, ~30% operating, and stable — a moat tell (see Lesson 3).
• Moat: switching costs (ecosystem) + intangibles (brand). Verify it in the numbers: margins and share hold up over years, not just in the pitch.
• Capital allocation: ~$80 B/yr of buybacks below-or-around intrinsic value shrinks the share count, lifting EPS even if net income is flat.

Verdict: high quality. This clears the highest bar. But quality is only half the question — a wonderful business at a terrible price is still a bad investment.

Step 4 · Do the statements back it up?

Quick pass with the statements lens: revenue ~$390 B, FCF ~$100 B ≥ net income ~$95 B (profits are cash-backed, not accounting mirages), and a net-cash balance sheet (low financial risk). No red flags in this illustrative snapshot — receivables and inventory aren’t ballooning ahead of sales.

Key idea: you’re not re-auditing the company — you’re checking that the quality story is confirmed by cash, and hunting for anything that would break the thesis. Clean statements raise confidence; messy ones lower it.

Step 5 · What’s it worth? (valuation)

Now the hard part. Two methods, then triangulate — exactly the valuation lens.

A quick scenario DCF (illustrative)

Start from FCF ≈ $100 B, discount at WACC ≈ 8.5%, terminal growth ≈ 3%, and vary the 10-year growth assumption:

Multiples cross-check

P/E ~32× sits above the ~20–25× the business has historically commanded. On a multiples basis it looks full.

Put it together

• Fair-value range: roughly $150–230, base case ~$185.
• Price today: ~$200 — above the base case.
• Margin of safety: negative at $200. A value-minded investor wants to buy ~15–25% below fair value, i.e. ≤ ~$155–160.

Key idea: great company, full price. This is the most common professional outcome — and the discipline is to wait, not to rationalize. The trading plan (next) is how you profit from patience instead of fighting it.

Step 6 · Read the market (timing & confirmation)

Valuation says what; the market lens helps with when and whether the crowd is set up against you.

• Trend: price above the 200-day average = long-term uptrend; don’t short a quality compounder just because it’s expensive.
• Positioning: check insider activity (insider-trading) and institutional flows (institutional-ownership) — heavy insider selling or funds trimming would lower confidence.
• Catalysts: the next earnings call and any product/regulatory events (catalyst-calendar, earnings-call-analysis) can create the pullback you’re waiting for.

Step 7 · Decide & size

Roll it up into a decision summary — the same axes as InvestSkill’s signal block (decoded in Concepts):

Position size. Conviction and risk set size — not excitement. House rules for this example:

• Full target position: 5% of the portfolio (a core, not a punt).
• Never let one name exceed 8% (concentration cap, Lesson 6).
• Because the margin of safety is thin, start small and scale in on weakness rather than buying 5% at $200.

In the plugin: run result-validator on the analysis to score data quality and signal consistency before committing; portfolio-review checks the position against your existing holdings.

Step 8 · The trading plan (write it down)

This is what separates a professional from a hopeful. Decide the rules before emotion is involved, and write them where you’ll see them.

Key idea: a scale-in ladder means you don’t need to be right about the bottom. If it never pulls back, you own a small starter and missed nothing you were entitled to; if it falls, your average cost improves and your margin of safety widens.

The trade ticket

A one-line record for every entry keeps you honest:

2026-07-02 · AAPL · BUY 8 sh @ $172 · thesis: moat + buybacks · target FV $185 · size now 1.5%

Step 9 · Track the thesis

A position isn’t “set and forget.” A professional keeps a short monitoring dashboard and reviews it on a schedule.

Review cadence: every earnings report (quarterly) + on any major news.

What to watch (the KPIs the thesis depends on):

Thesis-invalidation triggers — sell/reassess if:

• Gross margin structurally breaks below, say, ~40% (moat eroding).
• Services growth stalls (the growth leg of the thesis is gone).
• Buybacks are halted and cash is redeployed into value-destructive M&A.
• A regulatory ruling permanently impairs the App Store or search economics.
• The original one-sentence thesis is no longer true.

Key idea: decide your sell triggers while you’re calm and objective — at purchase — not in the middle of a 20% drawdown when you’ll rationalize anything.

A monitoring journal entry (illustrative)

Q3 review · AAPL
  Gross margin 46.2% ✓   Services +12% ✓   Buybacks on pace ✓
  Price $210 (above base FV) → no adds; hold
  Thesis intact. Next check: next earnings + any App Store ruling.

Step 10 · The sell discipline

Professionals sell for four reasons — and “the price went up/down” is not one of them by itself:

1. The thesis broke — an invalidation trigger fired. Sell regardless of price.
2. A materially better opportunity exists — capital is finite.
3. Extreme overvaluation — price far exceeds even the bull case (trim/exit).
4. Position/risk management — it grew past your concentration cap, so trim back to target.

Key idea: “It’s up 40%” is not a reason to sell a compounder; “the moat is cracking” is. Selling winners early and holding losers hoping to “get back to even” is the single most common self-inflicted wound — anchor to the thesis, not to your cost basis.

A different playbook: a pre-profit growth stock

The loop never changes, but the emphasis does. For a young, unprofitable company (think a RKLB-style name):

The point: same disciplined loop, dialed to the risk. See a real, full end-to-end run across every skill in the Demo.

Key takeaways

• Run the same loop every time: idea → thesis → plan → analyze → decide → trading plan → monitor → review. Repeatable beats brilliant.
• Write the thesis and the sell triggers first, while you’re objective. Judge the position against them later.
• A great business at a full price is a “wait,” not a “buy.” The margin of safety is your edge.
• A trading plan (scale-in ladder + trim/exit rules) lets patience pay instead of guessing the bottom.
• Track a short KPI dashboard on a schedule; sell on a broken thesis, not on the quote.

Next / Related: see the loop applied to a very different stock in Case Study: AMD. Or back to the Learning Hub · revisit Valuation and Portfolio & Risk · then Choose a Skill to run this on a ticker, or watch a full run in the Demo.

Educational content only. Not financial advice. All figures are illustrative and rounded for teaching — not current data.